Biotech

All Articles

2 cancer cells biotechs merge, generating global footprint

.OncoC4 is actually taking AcroImmune-- as well as its in-house scientific manufacturing abilities--...

Amgen documents very first stage 3 gain for $400M chronic eczema drug

.Amgen has actually shared (PDF) the initial phase 3 data on its own $400 million chronic eczema med...

Biogen, UCB report phase 3 lupus gain after falling short earlier trial

.Biogen and UCB's bet one's bottom dollar developing into stage 3 on the back of a failed research s...

Aptadir hopes brand new RNA preventions can reverse tricky cancers cells

.Italian biotech Aptadir Therapeutics has actually launched with the assurance that its own pipeline...

Wave surfs DMD results to regulatory authorities' doors, delivering stock up

.Surge Life Sciences has actually fulfilled its target in a Duchenne muscular dystrophy (DMD) resear...

Sanofi picks brand-new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma fol...

Achilles drips cell treatment program, supports for unemployments after missing out on 'office practicality' targets

.Achilles Therapeutics has torn up its own strategy. The English biotech is actually quiting working...

Aligos trumpets period 2 MASH win, slashing liver excess fat as much as 46%

.Aligos Rehabs is actually trumpeting a midstage gain in metabolic-dysfunction associated steatohepa...

Basilea ratings $268M BARDA funding for antifungals, anti-biotics

.Basilea Pharmaceutica's job establishing new antifungals has acquired a significant improvement fro...

Capricor offers Europe legal rights to late-stage DMD treatment for $35M

.Possessing currently scooped up the united state liberties to Capricor Therapies' late-stage Duchen...